GLP-1 receptor agonists such as semaglutide and liraglutide have shown reductions in ApoB, ApoC3, NT-proBNP, and IL-6 levels
The following labs are the minimum reasonable panel: IGF-1 (serum): Baseline, 8 weeks into cycle, 4 weeks post-cycle
Patient safety issues in the GLP-1 space this week Post found on Reddit, March 2025 GLP-1s are revolutionary medicines that can make a huge difference in the lives of diabetics and people suffering from obesity, but they come with significant side effects and must be prescribed by a doctor
Pore Refinement : Minimizes enlarged pores and balances skin texture
The formal pharmacokinetic data showing a 33% increase in levothyroxine exposure was studied with oral semaglutide specifically, but injectable formulations of both drugs also slow gastric emptying enough to affect thyroid medication absorption